RSS feed

Publications by Halvor Rollag

156 publications found

Original articles

Blom KB, Birkeland GK, Midtvedt K, Jenssen TG, Reisæter AV, Rollag H, Hartmann A, Sagedal S, Sjaastad I, Tylden G, Njølstad G, Nilsen E, Christensen A, Åsberg A, Birkeland JA (2023)
Cytomegalovirus High-risk Kidney Transplant Recipients Show No Difference in Long-term Outcomes Following Preemptive Versus Prophylactic Management
Transplantation, 107 (8), 1846-1853
DOI 10.1097/TP.0000000000004615, PubMed 37211633

Barlinn R, Dudman SG, Rollag H, Trogstad L, Lindstrøm JC, Magnus P (2022)
Maternal cytomegalovirus infection and delayed language development in children at 3 years of age-a nested case-control study in a large population-based pregnancy cohort
PLoS One, 17 (12), e0278623
DOI 10.1371/journal.pone.0278623, PubMed 36455052

Barlinn R, Trogstad L, Rollag H, Frøen F, Magnus P, Dudman SG (2020)
Parvovirus B19 DNAemia in pregnant women in relation to perinatal death: A nested case-control study within a large population-based pregnancy cohort
Acta Obstet Gynecol Scand, 99 (7), 856-864
DOI 10.1111/aogs.13801, PubMed 31925774

Richardson AK, Walker LC, Cox B, Rollag H, Robinson BA, Morrin H, Pearson JF, Potter JD, Paterson M, Surcel HM, Pukkala E, Currie MJ (2019)
Breast cancer and cytomegalovirus
Clin Transl Oncol, 22 (4), 585-602
DOI 10.1007/s12094-019-02164-1, PubMed 31256361

Barlinn R, Dudman SG, Trogstad L, Gibory M, Muller F, Magnus P, Rollag H (2018)
Maternal and congenital cytomegalovirus infections in a population-based pregnancy cohort study
APMIS, 126 (12), 899-906
DOI 10.1111/apm.12899, PubMed 30378168

Barlinn R, Rollag H, Trogstad L, Vainio K, Basset C, Magnus P, Dudman SG (2017)
High incidence of maternal parvovirus B19 infection in a large unselected population-based pregnancy cohort in Norway
J Clin Virol, 94, 57-62
DOI 10.1016/j.jcv.2017.07.010, PubMed 28759773

Smedbråten J, Mjøen G, Hartmann A, Åsberg A, Rollag H, Mollnes TE, Sandvik L, Fagerland MW, Thiel S, Sagedal S (2016)
Low level of MAp44, an inhibitor of the lectin complement pathway, and long-term graft and patient survival; a cohort study of 382 kidney recipients
BMC Nephrol, 17 (1), 148
DOI 10.1186/s12882-016-0373-9, PubMed 27760523

Smedbråten J, Sagedal S, Åsberg A, Hartmann A, Rollag H, Mjøen G, Fagerland MW, Hansen SW, Mollnes TE, Thiel S (2016)
Collectin Liver 1 and Collectin Kidney 1 of the Lectin Complement Pathway Are Associated With Mortality After Kidney Transplantation
Am J Transplant, 17 (1), 265-271
DOI 10.1111/ajt.13933, PubMed 27341702

Åsberg A, Humar A, Rollag H, Jardine AG, Kumar D, Aukrust P, Ueland T, Bignamini AA, Hartmann A (2016)
Lessons Learned From a Randomized Study of Oral Valganciclovir Versus Parenteral Ganciclovir Treatment of Cytomegalovirus Disease in Solid Organ Transplant Recipients: The VICTOR Trial
Clin Infect Dis, 62 (9), 1154-60
DOI 10.1093/cid/ciw084, PubMed 26908810

Béziat V, Sleiman M, Goodridge JP, Kaarbø M, Liu LL, Rollag H, Ljunggren HG, Zimmer J, Malmberg KJ (2015)
Polyclonal Expansion of NKG2C(+) NK Cells in TAP-Deficient Patients
Front Immunol, 6, 507
DOI 10.3389/fimmu.2015.00507, PubMed 26500647

Lisboa LF, Egli A, O'Shea D, Åsberg A, Hartmann A, Rollag H, Pang XL, Tyrrell DL, Kumar D, Humar A (2015)
Hcmv-miR-UL22A-5p: A Biomarker in Transplantation With Broad Impact on Host Gene Expression and Potential Immunological Implications
Am J Transplant, 15 (7), 1893-902
DOI 10.1111/ajt.13222, PubMed 25833298

Smedbråten YV, Sagedal S, Mjøen G, Hartmann A, Fagerland MW, Rollag H, Mollnes TE, Thiel S (2015)
High ficolin-3 level at the time of transplantation is an independent risk factor for graft loss in kidney transplant recipients
Transplantation, 99 (4), 791-6
DOI 10.1097/TP.0000000000000422, PubMed 25222012

Ueland T, Rollag H, Hartmann A, Jardine A, Humar A, Bignamini AA, Åsberg A, Aukrust P (2015)
Increased osteoprotegerin predicts poor virological outcome during anticytomegalovirus therapy in solid organ transplant recipients
Transplantation, 99 (1), 100-5
DOI 10.1097/TP.0000000000000227, PubMed 24983306

Turowski G, Rollag H, Roald B (2014)
Viral infection in placenta relevant cells--a morphological and immunohistochemical cell culture study
APMIS, 123 (1), 60-4
DOI 10.1111/apm.12307, PubMed 25244625

Husøy MA, Brinch L, Tjønnfjord GE, Gedde-Dahl T, Heldal D, Holme PA, Dybedal I, Kolstad A, Akkök ÇA, Rollag H, Gaustad P, Bergan S, Egeland T, Josefsen D, Kvalheim G, Fløisand Y (2014)
[Allogeneic stem-cell transplantation in adults 1985-2012: results and development]
Tidsskr Nor Laegeforen, 134 (16), 1569-75
DOI 10.4045/tidsskr.13.1415, PubMed 25178233

Taraldsrud E, Fevang B, Aukrust P, Beiske KH, Fløisand Y, Frøland S, Rollag H, Olweus J (2014)
Common variable immunodeficiency revisited: normal generation of naturally occurring dendritic cells that respond to Toll-like receptors 7 and 9
Clin Exp Immunol, 175 (3), 439-48
DOI 10.1111/cei.12239, PubMed 24237110

Smedbråten YV, Sagedal S, Leivestad T, Mjøen G, Osnes K, Rollag H, Reisaeter AV, Foss A, Os I, Hartmann A (2013)
The impact of early cytomegalovirus infection after kidney transplantation on long-term graft and patient survival
Clin Transplant, 28 (1), 120-6
DOI 10.1111/ctr.12288, PubMed 24351078

Ueland T, Rollag H, Hartmann A, Jardine AG, Humar A, Michelsen AE, Bignamini AA, Åsberg A, Aukrust P (2013)
Secreted Wnt antagonists during eradication of cytomegalovirus infection in solid organ transplant recipients
Am J Transplant, 14 (1), 210-5
DOI 10.1111/ajt.12506, PubMed 24224707

Razonable RR, Åsberg A, Rollag H, Duncan J, Boisvert D, Yao JD, Caliendo AM, Humar A, Do TD (2013)
Virologic suppression measured by a cytomegalovirus (CMV) DNA test calibrated to the World Health Organization international standard is predictive of CMV disease resolution in transplant recipients
Clin Infect Dis, 56 (11), 1546-53
DOI 10.1093/cid/cit096, PubMed 23418272

Rollag H, Ueland T, Asberg A, Hartmann A, Jardine AG, Humar A, Pescovitz MD, Bignamini AA, Aukrust P (2013)
Characterization of cytomegalovirus disease in solid organ transplant recipients by markers of inflammation in plasma
PLoS One, 8 (4), e60767
DOI 10.1371/journal.pone.0060767, PubMed 23593305

Rollag H, Asberg A, Ueland T, Hartmann A, Jardine AG, Humar A, Pescovitz MD, Bignamini AA, Aukrust P (2012)
Treatment of cytomegalovirus disease in solid organ transplant recipients: markers of inflammation as predictors of outcome
Transplantation, 94 (10), 1060-5
DOI 10.1097/TP.0b013e31826c39de, PubMed 23104251

Brantsæter AB, Johannessen A, Holberg-Petersen M, Sandvik L, Naman E, Kivuyo SL, Rollag H, Bruun JN, Kvale D (2012)
Cytomegalovirus viremia in dried blood spots is associated with an increased risk of death in HIV-infected patients: a cohort study from rural Tanzania
Int J Infect Dis, 16 (12), e879-85
DOI 10.1016/j.ijid.2012.08.003, PubMed 23031419

Emery VC, Manuel O, Asberg A, Pang X, Kumar D, Hartmann A, Preiksaitis JK, Pescovitz MD, Rollag H, Jardine AG, Gahlemann CG, Humar A (2012)
Differential decay kinetics of human cytomegalovirus glycoprotein B genotypes following antiviral chemotherapy
J Clin Virol, 54 (1), 56-60
DOI 10.1016/j.jcv.2012.01.015, PubMed 22410132

Ranneberg-Nilsen T, Rollag H, Slettebakk R, Backe PH, Olsen Ø, Luna L, Bjørås M (2012)
The chromatin remodeling factor SMARCB1 forms a complex with human cytomegalovirus proteins UL114 and UL44
PLoS One, 7 (3), e34119
DOI 10.1371/journal.pone.0034119, PubMed 22479537

Lisboa LF, Tong Y, Kumar D, Pang XL, Asberg A, Hartmann A, Rollag H, Jardine AG, Pescovitz MD, Humar A (2011)
Analysis and clinical correlation of genetic variation in cytomegalovirus
Transpl Infect Dis, 14 (2), 132-40
DOI 10.1111/j.1399-3062.2011.00685.x, PubMed 22093996

Myhre HA, Haug Dorenberg D, Kristiansen KI, Rollag H, Leivestad T, Asberg A, Hartmann A (2011)
Incidence and outcomes of ganciclovir-resistant cytomegalovirus infections in 1244 kidney transplant recipients
Transplantation, 92 (2), 217-23
DOI 10.1097/TP.0b013e31821fad25, PubMed 21685829

Lisboa LF, Asberg A, Kumar D, Pang X, Hartmann A, Preiksaitis JK, Pescovitz MD, Rollag H, Jardine AG, Humar A (2011)
The clinical utility of whole blood versus plasma cytomegalovirus viral load assays for monitoring therapeutic response
Transplantation, 91 (2), 231-6
DOI 10.1097/TP.0b013e3181ff8719, PubMed 21048530

Asberg A, Jardine AG, Bignamini AA, Rollag H, Pescovitz MD, Gahlemann CC, Humar A, Hartmann A, VICTOR Study Group (2010)
Effects of the intensity of immunosuppressive therapy on outcome of treatment for CMV disease in organ transplant recipients
Am J Transplant, 10 (8), 1881-8
DOI 10.1111/j.1600-6143.2010.03114.x, PubMed 20486914

Cox B, Richardson A, Graham P, Gislefoss RE, Jellum E, Rollag H (2010)
Breast cancer, cytomegalovirus and Epstein-Barr virus: a nested case-control study
Br J Cancer, 102 (11), 1665-9
DOI 10.1038/sj.bjc.6605675, PubMed 20407437

Manuel O, Asberg A, Pang X, Rollag H, Emery VC, Preiksaitis JK, Kumar D, Pescovitz MD, Bignamini AA, Hartmann A, Jardine AG, Humar A (2009)
Impact of genetic polymorphisms in cytomegalovirus glycoprotein B on outcomes in solid-organ transplant recipients with cytomegalovirus disease
Clin Infect Dis, 49 (8), 1160-6
DOI 10.1086/605633, PubMed 19751151

Asberg A, Humar A, Jardine AG, Rollag H, Pescovitz MD, Mouas H, Bignamini A, Töz H, Dittmer I, Montejo M, Hartmann A, VICTOR Study Group (2009)
Long-term outcomes of CMV disease treatment with valganciclovir versus IV ganciclovir in solid organ transplant recipients
Am J Transplant, 9 (5), 1205-13
DOI 10.1111/j.1600-6143.2009.02617.x, PubMed 19422345

Boivin G, Goyette N, Rollag H, Jardine AG, Pescovitz MD, Asberg A, Ives J, Hartmann A, Humar A (2009)
Cytomegalovirus resistance in solid organ transplant recipients treated with intravenous ganciclovir or oral valganciclovir
Antivir Ther, 14 (5), 697-704
PubMed 19704173

Humar A, Asberg A, Kumar D, Hartmann A, Moussa G, Jardine A, Rollag H, Mouas H, Gahlemann CG, Pescovitz MD, VICTOR study group (2008)
An assessment of herpesvirus co-infections in patients with CMV disease: correlation with clinical and virologic outcomes
Am J Transplant, 9 (2), 374-81
DOI 10.1111/j.1600-6143.2008.02501.x, PubMed 19120074

Sagedal S, Thiel S, Hansen TK, Mollnes TE, Rollag H, Hartmann A (2008)
Impact of the complement lectin pathway on cytomegalovirus disease early after kidney transplantation
Nephrol Dial Transplant, 23 (12), 4054-60
DOI 10.1093/ndt/gfn355, PubMed 18577532

Ranneberg-Nilsen T, Dale HA, Luna L, Slettebakk R, Sundheim O, Rollag H, Bjørås M (2008)
Characterization of human cytomegalovirus uracil DNA glycosylase (UL114) and its interaction with polymerase processivity factor (UL44)
J Mol Biol, 381 (2), 276-88
DOI 10.1016/j.jmb.2008.05.028, PubMed 18599070

Valderhaug TG, Hjelmesaeth J, Rollag H, Leivestad T, Røislien J, Jenssen T, Hartmann A (2007)
Reduced incidence of new-onset posttransplantation diabetes mellitus during the last decade
Transplantation, 84 (9), 1125-30
DOI 10.1097/01.tp.0000287191.45032.38, PubMed 17998867

Arora S, Jenum PA, Aukrust P, Rollag H, Andreassen AK, Simonsen S, Gude E, Fiane AE, Geiran O, Gullestad L (2007)
Pre-transplant Toxoplasma gondii seropositivity among heart transplant recipients is associated with an increased risk of all-cause and cardiac mortality
J Am Coll Cardiol, 50 (20), 1967-72
DOI 10.1016/j.jacc.2007.07.068, PubMed 17996562

Asberg A, Humar A, Rollag H, Jardine AG, Mouas H, Pescovitz MD, Sgarabotto D, Tuncer M, Noronha IL, Hartmann A, VICTOR Study Group (2007)
Oral valganciclovir is noninferior to intravenous ganciclovir for the treatment of cytomegalovirus disease in solid organ transplant recipients
Am J Transplant, 7 (9), 2106-13
DOI 10.1111/j.1600-6143.2007.01910.x, PubMed 17640310

Sagedal S, Rollag H, Hartmann A (2007)
Cytomegalovirus infection in renal transplant recipients is associated with impaired survival irrespective of expected mortality risk
Clin Transplant, 21 (3), 309-13
DOI 10.1111/j.1399-0012.2006.00639.x, PubMed 17488378

Kvale EO, Fløisand Y, Lund-Johansen F, Rollag H, Farkas L, Ghanekar S, Brandtzaeg P, Jahnsen FL, Olweus J (2006)
Plasmacytoid DCs regulate recall responses by rapid induction of IL-10 in memory T cells
Blood, 109 (8), 3369-76
DOI 10.1182/blood-2006-06-031484, PubMed 17158235

Ranneberg-Nilsen T, Bjørås M, Luna L, Slettebakk R, Dale HA, Seeberg E, Rollag H (2006)
Human cytomegalovirus infection modulates DNA base excision repair in fibroblast cells
Virology, 348 (2), 389-97
DOI 10.1016/j.virol.2006.01.001, PubMed 16476462

Kvale EØ, Dalgaard J, Lund-Johansen F, Rollag H, Farkas L, Midtvedt K, Jahnsen FL, Brinchmann JE, Olweus J (2005)
CD11c+ dendritic cells and plasmacytoid DCs are activated by human cytomegalovirus and retain efficient T cell-stimulatory capability upon infection
Blood, 107 (5), 2022-9
DOI 10.1182/blood-2005-05-2016, PubMed 16269620

Hjelmesaeth J, Sagedal S, Hartmann A, Rollag H, Egeland T, Hagen M, Nordal KP, Jenssen T (2004)
Asymptomatic cytomegalovirus infection is associated with increased risk of new-onset diabetes mellitus and impaired insulin release after renal transplantation
Diabetologia, 47 (9), 1550-6
DOI 10.1007/s00125-004-1499-z, PubMed 15338129

Sagedal S, Hartmann A, Nordal KP, Osnes K, Leivestad T, Foss A, Degré M, Fauchald P, Rollag H (2004)
Impact of early cytomegalovirus infection and disease on long-term recipient and kidney graft survival
Kidney Int, 66 (1), 329-37
DOI 10.1111/j.1523-1755.2004.00735.x, PubMed 15200441

Nordøy I, Rollag H, Lien E, Sindre H, Degré M, Aukrust P, Frøland SS, Müller F (2003)
Cytomegalovirus infection induces production of human interleukin-10 in macrophages
Eur J Clin Microbiol Infect Dis, 22 (12), 737-41
DOI 10.1007/s10096-003-1028-x, PubMed 14610657

Sagedal S, Nordal KP, Hartmann A, Midtvedt K, Foss A, Asberg A, Degré M, Fauchald P, Rollag H (2003)
Pre-emptive therapy of CMVpp65 antigen positive renal transplant recipients with oral ganciclovir: a randomized, comparative study
Nephrol Dial Transplant, 18 (9), 1899-908
DOI 10.1093/ndt/gfg302, PubMed 12937241

Sagedal S, Nordal KP, Hartmann A, Sund S, Scott H, Degré M, Foss A, Leivestad T, Osnes K, Fauchald P, Rollag H (2002)
The impact of cytomegalovirus infection and disease on rejection episodes in renal allograft recipients
Am J Transplant, 2 (9), 850-6
DOI 10.1034/j.1600-6143.2002.20907.x, PubMed 12392291

Rollag H, Sagedal S, Kristiansen KI, Kvale D, Holter E, Degré M, Nordal KP (2002)
Cytomegalovirus DNA concentration in plasma predicts development of cytomegalovirus disease in kidney transplant recipients
Clin Microbiol Infect, 8 (7), 431-4
DOI 10.1046/j.1469-0691.2002.00449.x, PubMed 12199854

Degré M, Ranneberg-Nilsen T, Beck S, Rollag H, Fiane AE (2001)
Human cytomegalovirus productively infects porcine endothelial cells in vitro
Transplantation, 72 (7), 1334-7
DOI 10.1097/00007890-200110150-00028, PubMed 11602867

Degré M, Kristiansen KI, Rollag H, Holter E, Nordal KP (2001)
Detection of human cytomegalovirus (HCMV) pp67-mRNA and pp65 antigenemia in relation to development of clinical HCMV disease in renal transplant recipients
Clin Microbiol Infect, 7 (5), 254-60
DOI 10.1046/j.1198-743x.2001.00251.x, PubMed 11422252

Moens U, Van Ghelue M, Kristoffersen AK, Johansen B, Rekvig OP, Degré M, Rollag H (2001)
Simian virus 40 large T-antigen, but not small T-antigen, trans-activates the human cytomegalovirus major immediate early promoter
Virus Genes, 23 (2), 215-26
DOI 10.1023/a:1011877112214, PubMed 11724277

Sagedal S, Nordal KP, Hartmann A, Degré M, Holter E, Foss A, Osnes K, Leivestad T, Fauchald P, Rollag H (2000)
A prospective study of the natural course of cytomegalovirus infection and disease in renal allograft recipients
Transplantation, 70 (8), 1166-74
DOI 10.1097/00007890-200010270-00007, PubMed 11063335

Nordøy I, Müller F, Nordal KP, Rollag H, Aukrust P, Frøland SS (2000)
Chemokines and soluble adhesion molecules in renal transplant recipients with cytomegalovirus infection
Clin Exp Immunol, 120 (2), 333-7
DOI 10.1046/j.1365-2249.2000.01221.x, PubMed 10792384

Sindre H, Haraldsen G, Beck S, Hestdal K, Kvale D, Brandtzaeg P, Degré M, Rollag H (2000)
Human intestinal endothelium shows high susceptibility to cytomegalovirus and altered expression of adhesion molecules after infection
Scand J Immunol, 51 (4), 354-60
DOI 10.1046/j.1365-3083.2000.00676.x, PubMed 10736107

Sindre H, Rollag H, Olafsen MK, Degré M, Hestdal K (2000)
Human cytomegalovirus induces apoptosis in the hematopoietic cell line MO7e
APMIS, 108 (3), 223-30
DOI 10.1034/j.1600-0463.2000.d01-48.x, PubMed 10752692

Nordøy I, Müller F, Nordal KP, Rollag H, Lien E, Aukrust P, Froland SS (2000)
The role of the tumor necrosis factor system and interleukin-10 during cytomegalovirus infection in renal transplant recipients
J Infect Dis, 181 (1), 51-7
DOI 10.1086/315184, PubMed 10608750

Solheim BG, Rollag H, Svennevig JL, Arafa O, Fosse E, Bergerud U (2000)
Viral safety of solvent/detergent-treated plasma
Transfusion, 40 (1), 84-90
DOI 10.1046/j.1537-2995.2000.40010084.x, PubMed 10644817

Sindre H, Rollag H, Degré M, Hestdal K (2000)
Human cytomegalovirus induced inhibition of hematopoietic cell line growth is initiated by events taking place before translation of viral gene products
Arch Virol, 145 (1), 99-111
DOI 10.1007/s007050050008, PubMed 10664409

Nordøy I, Müller F, Nordal KP, Rollag H, Lien E, Aukrust P, Frøland SS (1999)
Immunologic parameters as predictive factors of cytomegalovirus disease in renal allograft recipients
J Infect Dis, 180 (1), 195-8
DOI 10.1086/314849, PubMed 10353879

Bruun T, Kristoffersen AK, Rollag H, Beck S, Degré M (1998)
Herpes simplex virus type 1 inhibits in vitro differentiation and selected functions of human blood-derived monocytes
APMIS, 106 (12), 1194-203
DOI 10.1111/j.1699-0463.1998.tb00277.x, PubMed 10052729

Bruun T, Kristoffersen AK, Rollag H, Degré M (1998)
Interaction of herpes simplex virus with mononuclear phagocytes is dependent on the differentiation stage of the cells
APMIS, 106 (2), 305-14
DOI 10.1111/j.1699-0463.1998.tb01351.x, PubMed 9531964

Rollag H, Sagedal S, Holter E, Degré M, Ariansen S, Nordal KP (1998)
Diagnosis of cytomegalovirus infection in kidney transplant recipients by a quantitative RNA-DNA hybrid capture assay for cytomegalovirus DNA in leukocytes
Eur J Clin Microbiol Infect Dis, 17 (2), 124-7
DOI 10.1007/BF01682170, PubMed 9629980

Rollag H, Solheim BG, Svennevig JL (1998)
Viral safety of blood derivatives by immune neutralization
Vox Sang, 74 Suppl 1, 213-7
DOI 10.1111/j.1423-0410.1998.tb05475.x, PubMed 9789531

Kristoffersen AK, Johnsen JI, Seternes OM, Rollag H, Degré M, Traavik T (1997)
The human polyomavirus BK T antigen induces gene expression in human cytomegalovirus
Virus Res, 52 (1), 61-71
DOI 10.1016/s0168-1702(97)00100-7, PubMed 9453145

Børsum K, Aksnes J, Müller F, Hagve TA, Kierulf P, Rollag H (1997)
Modification of mononuclear cell function after incubation with albumin-bound unsaturated fatty acids or soybean oil emulsion
APMIS, 105 (9), 671-9
DOI 10.1111/j.1699-0463.1997.tb05070.x, PubMed 9350210

Kristoffersen AK, Sindre H, Mándi Y, Rollag H, Degré M (1997)
Effect of adenovirus 2 on cellular gene activation in blood-derived monocytes and macrophages
APMIS, 105 (5), 402-9
DOI 10.1111/j.1699-0463.1997.tb00587.x, PubMed 9201242

Holberg-Petersen M, Rollag H, Beck S, Degré M (1997)
The effect of human cytomegalovirus on selected functions of peripheral blood monocytes
APMIS, 105 (2), 89-98
DOI 10.1111/j.1699-0463.1997.tb00546.x, PubMed 9113070

Holberg-Petersen M, Høgåsen AK, Høgåsen K, Abrahamsen TG, Degré M, Rollag H (1997)
Infection with human cytomegalovirus (HCMV) stimulates monocyte production of complement factor 3
Arch Virol, 142 (4), 689-98
DOI 10.1007/s007050050111, PubMed 9170497

Sindre H, Tjøonnfjord GE, Rollag H, Ranneberg-Nilsen T, Veiby OP, Beck S, Degré M, Hestdal K (1996)
Human cytomegalovirus suppression of and latency in early hematopoietic progenitor cells
Blood, 88 (12), 4526-33
DOI 10.1182/blood.V88.12.4526.bloodjournal88124526, PubMed 8977244

Holberg-Petersen M, Rollag H, Beck S, Overli I, Tjønnfjord G, Abrahamsen TG, Degré M, Hestdal K (1996)
Direct growth suppression of myeloid bone marrow progenitor cells but not cord blood progenitors by human cytomegalovirus in vitro
Blood, 88 (7), 2510-6
DOI 10.1182/blood.V88.7.2510.bloodjournal8872510, PubMed 8839843

Aksnes J, Børsum K, Rollag H, Hovig T (1996)
Intravascular lung macrophages play an essential role in lipid entrapment and the inflammatory tissue reaction seen after long-term lipid-based parenteral nutrition in pigs. An ultrastructural study
APMIS, 104 (6), 429-36
DOI 10.1111/j.1699-0463.1996.tb00738.x, PubMed 8774672

Haug CJ, Müller F, Rollag H, Aukrust P, Degré M, Frøland SS (1996)
The effect of 1,25-vitamin D3 on maturation of monocytes from HIV-infected patients varies with degree of immunodeficiency
APMIS, 104 (7-8), 539-48
DOI 10.1111/j.1699-0463.1996.tb04909.x, PubMed 8920807

Aksnes J, Børsum K, Hagve TA, Kierulf P, Müller F, Rollag H (1995)
Long-term lipid-based total parenteral nutrition activates mononuclear cells and modulates membrane lipid composition in pigs
Scand J Clin Lab Invest, 55 (3), 201-10
DOI 10.3109/00365519509089614, PubMed 7638553

Holberg-Petersen M, Bukholm G, Rollag H, Degré M (1994)
Infection with human cytomegalovirus enhances bacterial adhesiveness and invasiveness in permissive and semipermissive cells
APMIS, 102 (9), 703-10
DOI 10.1111/j.1699-0463.1994.tb05223.x, PubMed 7946274

Fauchald P, Leivestad T, Rollag H, Albrechtsen D, Sødal G (1994)
Influence of cytomegalovirus antibody status on graft survival in renal transplantation
Transplant Proc, 26 (3), 1725
PubMed 8030103

Kristoffersen AK, Taskèn K, Rollag H (1994)
Expression of protein kinase A and protein kinase C during ongoing human cytomegalovirus infection
Arch Virol, 138 (1-2), 85-93
DOI 10.1007/BF01310040, PubMed 7980013

Rollag H, Thorvaldsen J, Kittelsen P, Bjøro K, Frøland S (1993)
[Hepatitis C virus infections among persons attending special clinics dealing with problems related to social conditions]
Tidsskr Nor Laegeforen, 113 (19), 2397-400
PubMed 7690995

Foerster A, Bjørtuft O, Geiran O, Rollag H, Leivestad T, Frøysaker T (1993)
Single lung transplantation. Morphological surveillance by transbronchial biopsy
APMIS, 101 (6), 455-66
DOI 10.1111/j.1699-0463.1993.tb00134.x, PubMed 8395861

Hansen TW, Gaustad P, Rollag H, Abrahamsen TG, Finne PH (1993)
[Diagnosis and treatment of infections in a neonatal unit--viral infections, spirochete infections and toxoplasma infections]
Tidsskr Nor Laegeforen, 113 (14), 1701-5
PubMed 8322295

Stenseth AM, Rollag H, Degré M (1993)
Effect of in vitro acyclovir treatment on selected functions of blood-derived macrophages
Chemotherapy, 39 (3), 197-202
DOI 10.1159/000239126, PubMed 8508690

SOLHEIM BG, SVENNEVIG JL, MOHR B, DRAGSUND M, NODDELAND H, TOLLEFSRUD S, BROSSTAD F, ROLLAG H, MOLLNES TE (1993)
THE USE OF OCTAPLAS IN PATIENTS UNDERGOING OPEN-HEART-SURGERY
INT CONGR SER, 1044, 253-262

Degré M, Beck S, Rollag H (1992)
Interferon-gamma may enhance infection of blood-derived macrophages with HIV-1 in the presence of HIV-positive serum
APMIS, 100 (5), 465-9
DOI 10.1111/j.1699-0463.1992.tb00898.x, PubMed 1586484

Müller F, Holberg-Petersen M, Rollag H, Degré M, Brandtzaeg P, Frøland SS (1992)
Nonspecific oral immunity in individuals with HIV infection
J Acquir Immune Defic Syndr (1988), 5 (1), 46-51
PubMed 1371157

Lund MB, Simonsen S, Foerster A, Rollag H, Geiran O (1991)
[Gastrointestinal cytomegalovirus infection in patients with heart transplants]
Tidsskr Nor Laegeforen, 111 (28), 3385-7
PubMed 1665254

Degré M, Rollag H, Holter E, Tønjum T, Krajci Z, Bukholm G (1991)
[Diagnosis of cytomegalovirus infections in hospitalized patients]
Tidsskr Nor Laegeforen, 111 (28), 3401-4
PubMed 1665258

Brinch L, Evensen SA, Albrechtsen D, Egeland T, Solheim BG, Rollag H, Naalsund A, Jacobsen AB (1991)
[Allogeneic bone marrow transplantation in adults. Results after fractionated whole body irradiation and high dosage cyclophosphamide and use of HLA-compatible sibling donors]
Tidsskr Nor Laegeforen, 111 (3), 311-5
PubMed 2000610

Rollag H, Patou G, Pattison JR, Degré M, Evensen SA, Fröland SS, Glomstein A (1991)
Prevalence of antibodies against parvovirus B19 in Norwegians with congenital coagulation factor defects treated with plasma products from small donor pools
Scand J Infect Dis, 23 (6), 675-9
DOI 10.3109/00365549109024292, PubMed 1815327

Schrumpf E, Elgjo K, Fausa O, Haukenes G, Kvale D, Rollag H (1990)
The significance of anti-hepatitis C virus antibodies measured in chronic liver disease
Scand J Gastroenterol, 25 (11), 1169-74
DOI 10.3109/00365529008998550, PubMed 2177219

Müller F, Rollag H, Frøland SS (1990)
Reduced oxidative burst responses in monocytes and monocyte-derived macrophages from HIV-infected subjects
Clin Exp Immunol, 82 (1), 10-5
DOI 10.1111/j.1365-2249.1990.tb05396.x, PubMed 1976461

Müller F, Rollag H, Gaudernack G, Frøland SS (1990)
Impaired in vitro survival of monocytes from patients with HIV infection
Clin Exp Immunol, 81 (1), 25-30
DOI 10.1111/j.1365-2249.1990.tb05286.x, PubMed 1974179

Rollag H, Evensen SA, Frøland SS, Glomstein A (1990)
Serological markers of hepatitis B virus and cytomegalovirus infections in Norwegians with coagulation factor defects
Blut, 60 (2), 93-6
DOI 10.1007/BF01720514, PubMed 2154272

Müller F, Rollag H, Frøland SS (1990)
Effects of alpha- and beta-interferon on oxidative burst responses of monocytes and monocyte-derived macrophages from patients with HIV infection
J Biol Regul Homeost Agents, 4 (3), 93-7
PubMed 2135379

Müller F, Rollag H, Frøland SS (1989)
Nitroblue tetrazolium reduction in monocytes and monocyte-derived macrophages. Effect of oxidative burst stimulants and interferons
APMIS, 97 (6), 490-6
DOI 10.1111/j.1699-0463.1989.tb00821.x, PubMed 2472158

Rollag H, Degré M (1989)
Phagocytic activity and protein content of human monocytes cultivated in the presence of various homologous interferon preparations
J Biol Regul Homeost Agents, 3 (1), 39-44
PubMed 2472044

Skar AG, Middeldorp J, Gundersen T, Rollag H, Degrè M (1988)
Rapid diagnosis of genital herpes simplex infection by an indirect ELISA method
NIPH Ann, 11 (2), 59-65
PubMed 3247065

Høeg V, Schrumpf E, Blomhoff JP, Frøland S, Rollag H, Stokke O, Aasen AO (1988)
[Etiology of chronic pancreatitis]
Tidsskr Nor Laegeforen, 108 (31), 2834-7
PubMed 3201447

Lappegård KT, Benestad HB, Rollag H (1988)
Interferons affect oxygen metabolism in human neutrophil granulocytes
J Interferon Res, 8 (5), 665-77
DOI 10.1089/jir.1988.8.665, PubMed 2466914

Rollag H, Degré M (1988)
Effect of recombinant interferon-gamma on protein content, phagocytic, and cytotoxic activity of mouse peritoneal macrophages
J Interferon Res, 8 (2), 169-78
DOI 10.1089/jir.1988.8.169, PubMed 3132510

Rollag H, Mørland B (1988)
The effect of recombinant interferons on cathepsin B activity in human monocytes
Scand J Rheumatol Suppl, 76, 79-83
DOI 10.3109/03009748809102956, PubMed 2472002

Rollag H, Evensen SA, Frøland SS, Glomstein A (1987)
The significance of HIV antigen and HIV antibodies specific against envelope and core proteins in serum of HIV-infected hemophiliacs
Eur J Haematol, 39 (4), 353-5
DOI 10.1111/j.1600-0609.1987.tb00782.x, PubMed 3480236

Albrechtsen DH, Evensen SA, Frøland S, Stavem P, Lie SO, Steinbakk M, Rollag H, Solheim B, Thorsby E, Jacobsen AB (1987)
[Allogeneic bone marrow transplantation in Norway]
Tidsskr Nor Laegeforen, 107 (26), 2222-4
PubMed 3313797

Evensen SA, Ulstrup J, Skaug K, Frøland SS, Glomstein A, Rollag H (1987)
HIV infection in Norwegian haemophiliacs: the prevalence of antibodies against HIV in haemophiliacs treated with lyophilized cryoprecipitate from volunteer donors
Eur J Haematol, 39 (1), 44-8
DOI 10.1111/j.1600-0609.1987.tb00162.x, PubMed 3115823

von der Lippe E, Frøland S, Rollag H, Degre M (1986)
Effect of fibroblast interferon and recombinant gamma interferon on zymosan-induced nitroblue tetrazolium reduction in mouse peritoneal macrophages
Acta Pathol Microbiol Immunol Scand B, 94 (5), 343-6
DOI 10.1111/j.1699-0463.1986.tb03064.x, PubMed 3098042

Hovig B, Rollag H, Dahl O (1985)
Antibody to hepatitis B surface antigen among employees in the National Hospital, Oslo, Norway: a prevalence study
Am J Epidemiol, 122 (1), 127-34
DOI 10.1093/oxfordjournals.aje.a114071, PubMed 4014189

Kjeldsberg E, Rollag H, Lund H, Holberg-Pettersen M, Degré M (1985)
Effect of gamma interferon on spreading of mouse peritoneal macrophages on solid surfaces
Acta Pathol Microbiol Immunol Scand B, 93 (3), 165-70
DOI 10.1111/j.1699-0463.1985.tb02871.x, PubMed 3929557

Rollag H, Petersen G, Aars H, Siebke JC (1984)
[Venereal diseases in homosexual men]
Tidsskr Nor Laegeforen, 104 (30), 2083-6
PubMed 6548843

Rollag H, Degré M, Sonnenfeld G (1984)
Effects of interferon-alpha/beta and interferon-gamma preparations on phagocytosis by mouse peritoneal macrophages
Scand J Immunol, 20 (2), 149-55
DOI 10.1111/j.1365-3083.1984.tb00988.x, PubMed 6236548

Rollag H, Hovig T (1984)
Phagocytosis of non-opsonized Escherichia coli by mouse peritoneal macrophages. An electron microscopic study
Zentralbl Bakteriol Mikrobiol Hyg A, 257 (1), 93-107
DOI 10.1016/S0174-3031(84)80047-5, PubMed 6380159

Degré M, Belsnes K, Rollag H, Beck S, Sonnenfeld G (1983)
Influence of the genotype of mice on the effect of interferon on phagocytic activity of macrophages
Proc Soc Exp Biol Med, 173 (1), 27-31
DOI 10.3181/00379727-173-41604, PubMed 6344094

Rollag H, Degré M (1982)
Effect of beta-interferon on in vitro spreading of mouse peritoneal macrophages
Acta Pathol Microbiol Immunol Scand B, 90 (6), 389-95
DOI 10.1111/j.1699-0463.1982.tb00136.x, PubMed 7168315

Rollag H, Mørland B, Degré M (1982)
Effect of a homologous beta-interferon preparation on degradation of Escherichia coli and on lysosomal enzyme activities in mouse peritoneal macrophages
Acta Pathol Microbiol Immunol Scand B, 90 (2), 113-8
DOI 10.1111/j.1699-0463.1982.tb00091.x, PubMed 6177190

Degré M, Rollag H (1982)
Effect of murine beta-interferon preparation on phagocytosis and cyclic AMP levels in mouse peritoneal macrophages
J Interferon Res, 2 (2), 151-7
DOI 10.1089/jir.1982.2.151, PubMed 6288813

Rollag H, Degré M (1981)
Effect of interferon preparations on the uptake of non-opsonized Escherichia coli by mouse peritoneal macrophages
Acta Pathol Microbiol Scand B, 89 (3), 153-9
DOI 10.1111/j.1699-0463.1981.tb00169_89b.x, PubMed 6171991

Degré M, Sonnenfeld G, Rollag H, Mørland B (1981)
Effect of gamma interferon preparations on in vitro phagocytosis and degradation of Escherichia coli by mouse peritoneal macrophages
J Interferon Res, 1 (4), 505-12
DOI 10.1089/jir.1981.1.505, PubMed 6180084

Degré M, Rollag H (1980)
Pathogenesis of Sendasi virus infection in mice. On the possible role of interferon on the development of disease
Acta Pathol Microbiol Scand B, 88 (3), 177-81
PubMed 6160724

Rollag H (1980)
Degradation of non-opsonized 32P-labelled E. coli by unstimulated mouse peritoneal macrophages. Evaluation of a method
Acta Pathol Microbiol Scand C, 88 (3), 109-14
DOI 10.1111/j.1699-0463.1980.tb00081.x, PubMed 7004082

Melby K, Rollag H (1980)
[Amidinopenicillins (mecillinam and pivmecillinam). A new group of beta-lactamate antibiotics]
Tidsskr Nor Laegeforen, 100 (2), 105-6
PubMed 6246655

Degré M, Rollag H (1979)
Screening for rubella antibodies by a single radial haemolysis test
NIPH Ann, 2 (2), 25-30
PubMed 398458

Rollag H, Midtvedt T, Hovig B, Dahl O (1979)
Sensitivity patterns of bacteria and antibiotic usage at the National Hospital of Norway in 1976 and 1978
Zentralbl Bakteriol Orig A, 244 (4), 515-24
PubMed 543352

Degré M, Rollag H (1979)
Influence of interferon on the in vivo phagocytic activity of reticuloendothelial system cells
J Reticuloendothel Soc, 25 (5), 489-93
PubMed 458780

Rollag H (1979)
Uptake of non-opsonized E. coli by unstimulated mouse peritoneal macrophages
Acta Pathol Microbiol Scand C, 87C (2), 99-105
PubMed 375677

Rollag H, Midtvedt T (1978)
Comparative antibiotic sensitivity testing of bacteria with a paper disc and a tablet method
Chemotherapy, 24 (5), 297-300
DOI 10.1159/000237796, PubMed 668447

Rollag H, Melby K (1977)
[Ampicillin--pivampicillin--amoxicillin]
Tidsskr Nor Laegeforen, 97 (33), 1759-60
PubMed 244370

Rollag H, Holter O (1977)
[Acute cholecystitis]
Tidsskr Nor Laegeforen, 97 (7), 361-2
PubMed 847697

Rollag H, Hagen R (1977)
[Antibacterial treatment of septic arthritis]
Tidsskr Nor Laegeforen, 97 (3), 151-2
PubMed 835121

Rollag H, degré M (1976)
Effect of antibiotics on interferon production in mice
Acta Pathol Microbiol Scand B, 84B (6), 369-72
DOI 10.1111/j.1699-0463.1976.tb01954.x, PubMed 998256

Midtvedt T, Tvete E, Hovig B, Rollag H (1976)
A computer system for handling data from bacterial sensitivity testing
Comput Programs Biomed, 6 (3), 178-86
DOI 10.1016/0010-468x(76)90024-6, PubMed 1000977

Sodal G, Kvambe V, Rollag H, Fauchald P, Flatmark A (1976)
[Listeria meningitis in adults]
Tidsskr Nor Laegeforen, 96 (23), 1198-9
PubMed 968840

Berdal BP, Bergan T, Midtvedt T, Rollag H, Wetterhus S (1975)
[Penicillin V]
Tidsskr Nor Laegeforen, 95 (31), 1795-6
PubMed 810918

Rollag H, Midtvedt T, Wetterhus S (1975)
Serum levels of penicillin v after oral administration of pediatric preparations to healthy subjects
Acta Paediatr Scand, 64 (3), 421-4
DOI 10.1111/j.1651-2227.1975.tb03858.x, PubMed 808089

Otterstad JE, Rollag H, Hagen AG (1975)
[Retroperitoneal, mediastinal and subcutaneous emphysema and bacillary dysentery]
Tidsskr Nor Laegeforen, 95 (6), 359-61
PubMed 1092028

Rollag H, Berdal BP, Bergan T, Degré M, Hovig B, Midtvedt T (1975)
[Letter: Microstix and N-labstix "Ames"--unsafe for proving bacteriuria]
Tidsskr Nor Laegeforen, 95 (3), 198
PubMed 1118846

Review articles

Sagedal S, Hartmann A, Rollag H (2005)
The impact of early cytomegalovirus infection and disease in renal transplant recipients
Clin Microbiol Infect, 11 (7), 518-30
DOI 10.1111/j.1469-0691.2005.01190.x, PubMed 15966969

Degré M, Sagedal S, Rollag H (2005)
Viral infections in immunocompromised patients. A review
Acta Microbiol Immunol Hung, 52 (3-4), 351-62
DOI 10.1556/AMicr.52.2005.3-4.7, PubMed 16400875

Bukholm G, Rollag H (1995)
[Revolution in diagnostic microbiology. Needs, driving forces and consequences]
Tidsskr Nor Laegeforen, 115 (27), 3387-9
PubMed 7491583

Degré M, Rollag H (1981)
On the possible role of interferon in infections with non-viral agents
Tex Rep Biol Med, 41, 388-94
PubMed 6184830

Other articles

Rollag H (2015)
Compendium of microbiology and infection medications
Tidsskr. Nor. Laegeforen., 135 (18), 1671

Rollag H, Holter E, Muller F (2015)
Hearing loss in children in Ostfold county 2000-09
Tidsskr. Nor. Laegeforen., 135 (6), 511

Rollag H, Holter E, Müller F (2015)
[Re: Hearing loss in children in Östfold county 2000-09]
Tidsskr Nor Laegeforen, 135 (6), 513
DOI 10.4045/tidsskr.15.0262, PubMed 25806741

Hausken J, Klingenberg O, Mørkrid L, Rollag H, Foss A, Midtvedt K (2012)
Elevated troponin I and NT-proBNP at the time of transplantation may predict a major adverse cardiac event in the early postoperative period after renal transplantation
Transplantation, 94 (2), e15-6
DOI 10.1097/TP.0b013e31825b7633, PubMed 22820562

Asberg A, Jardine AG, Bignamini AA, Rollag H, Gahlemann CC, Humar A, Hartmann A (2011)
Response to letter about intensity of immunosuppressive therapy on outcome of treatment for CMV disease
Am J Transplant, 11 (5), 1103-4
DOI 10.1111/j.1600-6143.2011.03500.x, PubMed 21521477

Asberg A, Rollag H, Hartmann A (2010)
Valganciclovir for the prevention and treatment of CMV in solid organ transplant recipients
Expert Opin Pharmacother, 11 (7), 1159-66
DOI 10.1517/14656561003742954, PubMed 20367273

Arora S, Jenum PA, Aukrust P, Rollag H, Andreassen AK, Simonsen S, Guide E, Fiane AE, Geiran O, Gullestad L (2008)
Pre-transplant Toxoplasma gondii seropositivlty among heart transplant recipients and mortality - Reply
J. Am. Coll. Cardiol., 51 (18), 1827-1828
DOI 10.1016/j.jacc.2008.02.028

Hjelmesaeth J, Müller F, Jenssen T, Rollag H, Sagedal S, Hartmann A (2005)
Is there a link between cytomegalovirus infection and new-onset posttransplantation diabetes mellitus? Potential mechanisms of virus induced beta-cell damage
Nephrol Dial Transplant, 20 (11), 2311-5
DOI 10.1093/ndt/gfi033, PubMed 16046502

Solheim BG, Rollag H, Svennevig JL (2000)
Viral safety of solvent/detergent-treated plasma - Reply
Transfusion, 40 (9), 1150

Evensen SA, Rollag H, Glomstein A (1995)
Hepatitis C virus seroconversion in a hemophiliac treated exclusively with solvent/detergent-treated clotting factor concentrate
Eur J Clin Microbiol Infect Dis, 14 (7), 631-2
DOI 10.1007/BF01690743, PubMed 7588856

Degré M, Bukholm G, Holter E, Müller F, Rollag H (1994)
Rapid detection of cytomegalovirus infection in immunocompromised patients
Eur J Clin Microbiol Infect Dis, 13 (8), 668-70
DOI 10.1007/BF01973997, PubMed 7813501

Evensen SA, Rollag H (1993)
Solvent/detergent-treated clotting factors and hepatitis A virus seroconversion
Lancet, 341 (8850), 971-2
DOI 10.1016/0140-6736(93)91273-o, PubMed 8096316

Rollag H, Evesen SA, Fröland SS, Glomstein A (1990)
Prevalence of antibodies against hepatitis C virus in Norwegians with congenital coagulation factor defects treated with plasma products from small pools
Eur J Clin Microbiol Infect Dis, 9 (8), 612-4
DOI 10.1007/BF01967219, PubMed 2170135

Orstavik I, Siebke JC, Rollag H, Skaug K, Størvold G, Orjasoeter H (1989)
[Anti-hepatitis C (HCV) ELISA. A serologic test for non-A non-B hepatitis (NANBH) after blood transfusion]
Tidsskr Nor Laegeforen, 109 (34-36), 3648
PubMed 2515616

Degré M, Rollag H, Kjeldsberg E (1982)
Morphological parameters of the effect of interferon on mouse peritoneal macrophages
Philos Trans R Soc Lond B Biol Sci, 299 (1094), 131-3
DOI 10.1098/rstb.1982.0115, PubMed 6128749

Degré M, Rollag H (1979)
Rubella screening by hemolysis-in-gel-test
Lancet, 2 (8143), 644-5
PubMed 90314

Books

Degré M, Hovig B, Rollag H (2008)
Medisinsk mikrobiologi
Gyldendal, Oslo (3. utg.), 803 s.
BIBSYS 070202222, ISBN 978-82-05-31590-7

Rollag H (2007)
Strategimøte: virusinfeksjoner ved immunsvikt, 2. november 2006, Mor Gulbergstuen, Diakonissehuset : program, oppsummering og anbefalinger, sammendrag av forelesninger
Folkehelseinstituttet, Oslo, 67 s.
BIBSYS 08004669x, ISBN 978-82-8082-209-3

Rollag H (1999)
CMV strategimøte: diagnostikk ved cytomegalvirus-infeksjoner 12.november 1998 : oppsummering, anbefalinger og forelesningsmanuskripter
Statens institutt for folkehelse, Oslo, 46 s.
BIBSYS 060384271

Theses

Rollag H (1985)
Interferon effect on some activities of murine macrophages
Kaptein W. Wilhelmsen og frues bakteriologiske institutt,Rikshospitalet, Oslo, 1 b. (flere pag.)
BIBSYS 852167997